Among them, GPX2, GSTP1 and RRM2 (Ribonucleotide Reductase Regulatory Subunit M2) showed different expression levels in different stages of PAAD (Figure 5E) (**p_value < 0.01). This evidence concerns the gene GPX2 and pancreatic adenocarcinoma.